Statins as a preventive medicine for “invisible population”
“Invisible population” are people who aren't identified as at risk by screening programmes.
“Invisible population” are people who are at high risk when you include genetics.
If a genetic risk score was included in the screening programmes the statistics could change harshly.
Genetic test would move 528,000 adults who would have been missed, into the high-risk category.
About 4 million people are being treated with statins in England.
People with risky genetic profiles get the greatest benefits from preventative medication.
Genetic scores are very likely to play a role in the management of heart health in the next decade.